Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Catheter Precision (VTAK) Gross Profit (2017 - 2025)

Catheter Precision (VTAK) has disclosed Gross Profit for 9 consecutive years, with $208000.0 as the latest value for Q3 2025.

  • On a quarterly basis, Gross Profit rose 141.86% to $208000.0 in Q3 2025 year-over-year; TTM through Sep 2025 was $676000.0, a 87.26% increase, with the full-year FY2024 number at $378000.0, down 8.25% from a year prior.
  • Gross Profit was $208000.0 for Q3 2025 at Catheter Precision, up from $198000.0 in the prior quarter.
  • In the past five years, Gross Profit ranged from a high of $208000.0 in Q3 2025 to a low of -$559000.0 in Q4 2021.
  • A 5-year average of -$21000.0 and a median of $77000.0 in 2024 define the central range for Gross Profit.
  • Peak YoY movement for Gross Profit: tumbled 110.95% in 2021, then soared 245.9% in 2023.
  • Catheter Precision's Gross Profit stood at -$559000.0 in 2021, then soared by 89.09% to -$61000.0 in 2022, then skyrocketed by 298.36% to $121000.0 in 2023, then grew by 14.05% to $138000.0 in 2024, then soared by 50.72% to $208000.0 in 2025.
  • Per Business Quant, the three most recent readings for VTAK's Gross Profit are $208000.0 (Q3 2025), $198000.0 (Q2 2025), and $132000.0 (Q1 2025).